Detalhe da pesquisa
1.
Cytometric analysis of T cell phenotype using cytokine profiling for improved manufacturing of an EBV-specific T cell therapy.
Clin Exp Immunol
; 206(1): 68-81, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34146397
2.
What does cell therapy manufacturing cost? A framework and methodology to facilitate academic and other small-scale cell therapy manufacturing costings.
Cytotherapy
; 22(7): 388-397, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32414635
3.
Cytotoxic T-lymphocyte therapy for post-transplant lymphoproliferative disorder after solid organ transplantation in children.
Pediatr Transplant
; 22(2)2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29388302
4.
Establishment and operation of a Good Manufacturing Practice-compliant allogeneic Epstein-Barr virus (EBV)-specific cytotoxic cell bank for the treatment of EBV-associated lymphoproliferative disease.
Br J Haematol
; 167(3): 402-10, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25066775
5.
Long-term follow up after third-party viral-specific cytotoxic lymphocytes for immunosuppression- and Epstein-Barr virus-associated lymphoproliferative disease.
Haematologica
; 104(8): e356-e359, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30792197
6.
Bos taurus and Bos indicus (Sahiwal) calves respond differently to infection with Theileria annulata and produce markedly different levels of acute phase proteins.
Int J Parasitol
; 35(3): 337-47, 2005 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-15722085
7.
The protozoan parasite, Theileria annulata, induces a distinct acute phase protein response in cattle that is associated with pathology.
Int J Parasitol
; 33(12): 1409-18, 2003 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-14527523
8.
Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial.
Blood
; 110(4): 1123-31, 2007 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17468341
9.
Establishment and characterization of a bank of cytotoxic T lymphocytes for immunotherapy of epstein-barr virus-associated diseases.
J Immunother
; 27(4): 309-16, 2004.
Artigo
em Inglês
| MEDLINE | ID: mdl-15235392
10.
Treatment of Epstein-Barr-virus-positive post-transplantation lymphoproliferative disease with partly HLA-matched allogeneic cytotoxic T cells.
Lancet
; 360(9331): 436-42, 2002 Aug 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-12241714
11.
Interferon gamma (IFN-gamma) polymorphism in posttransplantation lymphoproliferative disease.
Blood
; 106(4): 1502-3; author reply 1503, 2005 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16079437
12.
Treatment of Epstein-Barr-virus-associated primary CNS B cell lymphoma with allogeneic T-cell immunotherapy and stem-cell transplantation.
Lancet Oncol
; 6(5): 344-6, 2005 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-15863383